

Cover Story
COVID-19 & CancerFree
By Matthew Bin Han Ong
Experts in infectious diseases and investors on Wall Street are honing in on two potential treatments for COVID-19: interleukin inhibitors and remdesivir.
COVID-19 Updates


In Brief
Clinical Roundup


Drugs & Targets
Trending Stories
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Cancer Research Institute announces 2025 recipients of cancer immunotherapy awards
- Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home